API | eprodisate

eprodisate (Kiacta) Report issue

Small molecule Experimental

AACT ChEMBL PubChem

Active Ingredient History

NOW

1,3-Propanedisulfonic acid is a sulfonic acid containing two sulfonate units. Its salts are called eprodisates and have been evaluated as a protector of renal function in AA amyloidosis. ^Wikipedia

Chemistry

SMILES: OS(=O)(=O)CCCS(=O)(=O)O
InChIKey: MGNVWUDMMXZUDI-UHFFFAOYSA-N
Mol. Mass: 204.22
ALogP: -0.85 Partition coefficient
ChEMBL Molecules:

eprodisate

eprodisate disodium

More Chemistry

Pharmacology

Mechanism of Action:
- 3-hydroxyacyl-CoA dehydrogenase type-2 (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

eprodisate | eprodisate disodium | nc-503

Organizations (3)

Research & Development (3)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (8)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (8)

Amyloidosis (Phase 3)

Arthritis, Rheumatoid (Phase 2/Phase 3)

Diabetes Mellitus, Type 2 (Phase 2)

Familial Mediterranean Fever (Phase 2/Phase 3)

Gastrointestinal Diseases (Phase 2/Phase 3)

Kidney Diseases (Phase 2/Phase 3)

Metabolic Syndrome (Phase 2)

Nephrotic Syndrome (Phase 2/Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 3
# of Trial Organizations: 3

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue